BioSpace News Archive

Business

Ligand Earns $6 Million as OmniAb Partner Out-Licenses Antibody Projects

Under the license agreements with HanAll, Ligand is eligible to receive milestones and royalties on the successful development of antibodies and to share sub-license revenue on out-licensed antibodies.

January 3, 2018
·
4 min read
FDA

Mevion Snags FDA 510(k) Clearance for HYPERSCAN Pencil Beam Scanning

HYPERSCAN PBS introduces novel energy layer switching and automated collimation systems.

January 3, 2018
·
5 min read
Business

Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility

In support of the Company’s growing operations, the 50,000-square-foot Barnes Canyon facility doubles its previous manufacturing capacity for both insulin pumps and cartridges and expands warehousing for additional infusion set supplies related to the launch of the Company’s new t:lock™ connector.

January 3, 2018
·
5 min read
Deals

McKesson Completes Acquisition of RxCrossroads

McKesson announced today that it has completed the previously announced acquisition of RxCrossroads.

January 3, 2018
·
1 min read
CanniMed Releases New Letter to Shareholders

Cannimed releases a new letter to shareholders highlighting the benefits of acquiring all of the issued and outstanding shares of Newstrike Resources Ltd. and warning of the risks posed by Aurora Cannabis Inc.’s hostile bid to acquire all of the common shares of the Company.

January 3, 2018
·
22 min read
Business

PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors

Hill is the chairman, chief executive officer and co-founder of GNS Healthcare, a leading precision medicine company.

January 3, 2018
·
3 min read
Genetown

Siamab Therapeutics to Present New Data on its ST1 Antibody Therapeutic Program Targeting Tumor-Associated STn and MDSCs at Biotech Showcase 2018

Siamab Therapeutics announced that Jeff Behrens, president and chief executive officer, will present at the 10th annual Biotech Showcase™ conference in San Francisco on Tuesday, January 9, 2018.

January 3, 2018
·
3 min read
Genetown

Tarveda Therapeutics Provides Year-End Update and Outlines Milestones for 2018

Tarveda Therapeutics will provide corporate updates throughout the year at industry events. Mr. Fromkin will provide the first of these updates at 10am PST on January 10th at the 2018 Biotech Showcase.

January 3, 2018
·
5 min read
Pharm Country

Spark Therapeutics Announces First-of-Their-Kind Programs to Improve Patient Access to LUXTURNA (voretigene neparvovec-rzyl), a One-time Gene Therapy Treatment

The company also has reached an agreement in principle with affiliates of Express Scripts to enable the innovative contracting model.

January 3, 2018
·
21 min read
Pressure Point to Present at the 2018 Cipher Ground Healthcare Investment and Strategy Conference in Shenzhen, China This Month

Cipher Ground a Chinese investment advisory group based in Beijing and the USA has invited Pressure Point to present their China project at the healthcare conference on January 16th.

January 3, 2018
·
3 min read